These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2109376)

  • 1. Delayed treatment with a t-PA analogue and streptokinase in a rabbit embolic stroke model.
    Phillips DA; Fisher M; Davis MA; Smith TW; Pang RH
    Stroke; 1990 Apr; 21(4):602-5. PubMed ID: 2109376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of a new tissue plasminogen activator analogue, Fb-Fb-CF, on cerebral reperfusion in a rabbit embolic stroke model.
    Phillips DA; Fisher M; Smith TW; Davis MA; Pang RH
    Ann Neurol; 1989 Mar; 25(3):281-5. PubMed ID: 2499244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of cerebral hemorrhage after treatment with tissue plasminogen activator or streptokinase following embolic stroke in rabbits [corrected].
    Lyden PD; Madden KP; Clark WM; Sasse KC; Zivin JA
    Stroke; 1990 Nov; 21(11):1589-93. PubMed ID: 2122552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intra-arterial tissue plasminogen activator and urokinase on autologous arterial emboli in the cerebral circulation of rabbits [corrected].
    Benes V; Zabramski JM; Boston M; Puca A; Spetzler RF
    Stroke; 1990 Nov; 21(11):1594-9. PubMed ID: 2122553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinolytic drugs prevent pericardial adhesions in the rabbit.
    Wiseman DM; Kamp L; Linsky CB; Jochen RF; Pang RH; Scholz PM
    J Surg Res; 1992 Oct; 53(4):362-8. PubMed ID: 1405617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A long-half-life and fibrin-specific form of tissue plasminogen activator in rabbit models of embolic stroke and peripheral bleeding.
    Thomas GR; Thibodeaux H; Errett CJ; Badillo JM; Keyt BA; Refino CJ; Zivin JA; Bennett WF
    Stroke; 1994 Oct; 25(10):2072-8; discussion 2078-9. PubMed ID: 8091454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thrombolytic therapy in ischemic infarct].
    Willig V; Steiner T; Hacke W
    Wien Klin Wochenschr; 1997 Oct; 109(20):795-803. PubMed ID: 9454430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue plasminogen activator. Reduction of neurologic damage after experimental embolic stroke.
    Zivin JA; Lyden PD; DeGirolami U; Kochhar A; Mazzarella V; Hemenway CC; Johnston P
    Arch Neurol; 1988 Apr; 45(4):387-91. PubMed ID: 3128254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved perfusion with rt-PA and hirulog in a rabbit model of embolic stroke.
    Yenari MA; de Crespigny A; Palmer JT; Roberts S; Schrier SL; Albers GW; Moseley ME; Steinberg GK
    J Cereb Blood Flow Metab; 1997 Apr; 17(4):401-11. PubMed ID: 9143222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thrombolysis in stroke].
    Diener HC; Hacke W
    Internist (Berl); 1996 Jun; 37(6):613-8. PubMed ID: 8767994
    [No Abstract]   [Full Text] [Related]  

  • 11. Tissue plasminogen activator-mediated thrombolysis of cerebral emboli and its effect on hemorrhagic infarction in rabbits.
    Lyden PD; Zivin JA; Clark WA; Madden K; Sasse KC; Mazzarella VA; Terry RD; Press GA
    Neurology; 1989 May; 39(5):703-8. PubMed ID: 2496332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemorrhagic complications of thrombolytic therapy in experimental stroke.
    Slivka A; Pulsinelli W
    Stroke; 1987; 18(6):1148-56. PubMed ID: 3120360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombolytic therapy in cerebrovascular disorders.
    Levine SR; Brott TG
    Prog Cardiovasc Dis; 1992; 34(4):235-62. PubMed ID: 1728786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke.
    del Zoppo GJ; Poeck K; Pessin MS; Wolpert SM; Furlan AJ; Ferbert A; Alberts MJ; Zivin JA; Wechsler L; Busse O
    Ann Neurol; 1992 Jul; 32(1):78-86. PubMed ID: 1642475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute myocardial infarction: is streptokinase really as effective as tissue plasminogen activator?
    Vine DL
    Kans Med; 1990 May; 91(5):147-8. PubMed ID: 2115093
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravenous thrombolysis with recombinant staphylokinase versus tissue-type plasminogen activator in a rabbit embolic stroke model.
    Vanderschueren S; Van Vlaenderen I; Collen D
    Stroke; 1997 Sep; 28(9):1783-8. PubMed ID: 9303026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteplase for thrombolysis in acute ischemic stroke.
    Med Lett Drugs Ther; 1996 Nov; 38(987):99-100. PubMed ID: 8914507
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group.
    Wolpert SM; Bruckmann H; Greenlee R; Wechsler L; Pessin MS; del Zoppo GJ
    AJNR Am J Neuroradiol; 1993; 14(1):3-13. PubMed ID: 8427107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolytic therapy with streptokinase and tissue plasminogen activator in a patient with suspected acute myocardial infarction: A decision analysis.
    Hiatt MD
    Cardiology; 1999; 91(4):243-9. PubMed ID: 10545680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct thrombin inhibition and thrombolytic therapy: rationale for the Hirulog and Early Reperfusion/Occlusion (HERO-2) trial.
    White HD
    Am J Cardiol; 1998 Oct; 82(8B):57P-62P. PubMed ID: 9809893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.